A new trading day began on Monday, with Guardant Health Inc (NASDAQ: GH) stock price up 0.33% from the previous day of trading, before settling in for the closing price of $30.44. GH’s price has ranged from $15.81 to $38.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 49.27% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 19.46%. With a float of $117.85 million, this company’s outstanding shares have now reached $123.16 million.
In an organization with 1779 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 81.07%, operating margin of -74.41%, and the pretax margin is -74.02%.
Guardant Health Inc (GH) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.61%, while institutional ownership is 103.02%. The most recent insider transaction that took place on Dec 18 ’24, was worth 4,043. In this transaction Director of this company sold 116 shares at a rate of $34.85, taking the stock ownership to the 2,810 shares. Before that another transaction happened on Dec 18 ’24, when Company’s Director proposed sale 116 for $34.85, making the entire transaction worth $4,043.
Guardant Health Inc (GH) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.20% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Here are Guardant Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.24, a number that is poised to hit -0.78 in the next quarter and is forecasted to reach -2.97 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Let’s dig in a bit further. During the last 5-days, its volume was 1.27 million. That was inferior than the volume of 2.02 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 10.31%. Additionally, its Average True Range was 1.50.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 56.55%, which indicates a significant increase from 8.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.02% in the past 14 days, which was lower than the 58.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.82, while its 200-day Moving Average is $26.11. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $31.22. Second resistance stands at $31.89. The third major resistance level sits at $32.55. If the price goes on to break the first support level at $29.89, it is likely to go to the next support level at $29.23. Assuming the price breaks the second support level, the third support level stands at $28.56.
Guardant Health Inc (NASDAQ: GH) Key Stats
With a market capitalization of 3.77 billion, the company has a total of 123,555K Shares Outstanding. Currently, annual sales are 563,950 K while annual income is -479,450 K. The company’s previous quarter sales were 191,480 K while its latest quarter income was -107,750 K.
